Armistice Capital’s Zura Bio ZURA Stock Holding History

Armistice Capital’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.65M	Buy	1,636,000 +129,000	+9%	+$614K	0.12%	113
2026 Q1	$8.97M	Sell	1,507,000 -53,000	-3%	-$320K	0.16%	97
2025 Q4	$8.17M	Hold	1,560,000	–	–	0.1%	110
2025 Q3	$6.75M	Buy	1,560,000 +24,000	+2%	+$43.2K	0.1%	98
2025 Q2	$1.61M	Hold	1,536,000	–	–	0.03%	140
2025 Q1	$1.98M	Buy	1,536,000 +36,000	+2%	+$56.8K	0.03%	149
2024 Q4	$3.75M	Hold	1,500,000	–	–	0.05%	128
2024 Q3	$6.09M	Sell	1,500,000 -1,024,000	-41%	-$3.83M	0.1%	112
2024 Q2	$8.83M	Buy	2,524,000 +876,000	+53%	+$3.57M	0.11%	97
2024 Q1	$4.24M	Sell	1,648,000 -176,000	-10%	-$624K	0.06%	129
2023 Q4	$8.52M	Buy	1,824,000 +244,000	+15%	+$1.22M	0.12%	99
2023 Q3	$10.4M	Buy	1,580,000 +630,000	+66%	+$4.21M	0.16%	85
2023 Q2	$7.79M	Buy	+950,000	New	+$7.63M	0.11%	103

Other funds holding ZURA

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Armistice Capital's ZURA Position: Q2 2026 in Review

Armistice Capital increased its Zura Bio (ZURA) stake by 8.6% in Q2 2026, buying an estimated $614K and bringing the position to 1,636,000 shares worth $9.65M. The position accounts for 0.12% of the portfolio, ranked #113.

Armistice Capital first reported a position in ZURA in Q2 2023 and has held it in 13 quarters since. The position peaked at $10.4M in Q3 2023. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

Armistice Capital held 1,636,000 shares of Zura Bio worth $9.65M as of Q2 2026.
Armistice Capital bought 129,000 Zura Bio shares in Q2 2026, an estimated $614K.
Zura Bio made up 0.12% of Armistice Capital's portfolio in Q2 2026, its #113 holding.
Armistice Capital first reported a position in Zura Bio in Q2 2023 and has held it in 13 quarters since.
Armistice Capital's Zura Bio position peaked at $10.4M in Q3 2023.
95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.